Wellington Management Company

Zero Hash partners with Current to provide access to no-fee crypto trading

Retrieved on: 
星期三, 十月 19, 2022

The integration with Zero Hash allows Current members access to buy and sell dozens of crypto assets without trading fees, including Bitcoin and Ethereum, in the Current app.

Key Points: 
  • The integration with Zero Hash allows Current members access to buy and sell dozens of crypto assets without trading fees, including Bitcoin and Ethereum, in the Current app.
  • Zero Hash provides the complete building blocks for supporting crypto trading, including liquidity, custody, and regulatory and compliance infrastructure.
  • Zero Hash brings the deep domain expertise of powering crypto products for some of the major consumer fintech platforms worldwide.
  • Against this backdrop, we are pleased to partner with Current on their first crypto product, said Edward Woodford, CEO of Zero Hash.

Top 500 asset managers reach new $131 trillion record

Retrieved on: 
星期一, 十月 17, 2022

ARLINGTON, Va., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Assets under management (AuM) at the worlds 500 largest asset managers reached a new record of over $131 trillion in 2021, according to new research from WTWs (NASDAQ: WTW) Thinking Ahead Institute.

Key Points: 
  • ARLINGTON, Va., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Assets under management (AuM) at the worlds 500 largest asset managers reached a new record of over $131 trillion in 2021, according to new research from WTWs (NASDAQ: WTW) Thinking Ahead Institute.
  • This is an increase of over 10% on the previous year, when assets had grown by 14.5% to over $119 trillion.
  • The worlds top 20 asset managers are now responsible for over $59 trillion of assets, having grown at an above-average annual rate of 13%.
  • In addition, the research reveals that BlackRock is both the worlds largest asset manager and the first to exceed $10 trillion.

Current migrates to Visa DPS Forward Platform; Innovative integration to enable suite of new financial products

Retrieved on: 
星期四, 十月 20, 2022

NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Current, a leading U.S. financial technology platform, today announced it has successfully migrated to the Visa DPS Forward platform with a seamless migration of over four million accounts. DPS Forward is a digital issuer processing platform built with REST APIs and designed to integrate with modern, digital banking cores to create unique card programs and payment solutions. This innovative integration allows for a deeper partnership between Visa, the world leader in digital payments, and Current that will enable the introduction of new financial products to all members on Current.

Key Points: 
  • The migration was completed on Current's proprietary core banking technology platform, which allowed for full control during the live payment network cutovers.
  • Through close cooperation with Visa, the new features DPS Forward offers became immediately available to all Current members without issuing new payment mechanisms.
  • "DPS Forward is an ideal match for Current's cloud-based approach to financial services," said Trevor Marshall, Chief Technology Officer, Current.
  • This integration comes after Current and Visa signed a new agreement in 2021 with a long-term commitment to the planning and building of innovative financial products together.

FalconX 360 Launches As The First and Only Comprehensive Platform for Institutional Crypto Investment Management

Retrieved on: 
星期四, 十月 13, 2022

SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- FalconX, a digital assets platform for institutional investors, today announced the launch of FalconX 360, the industry's first and only unified investment and risk management platform for crypto that provides institutional investors full-spectrum execution capabilities and end-to-end reporting across their entire digital asset portfolio.

Key Points: 
  • FalconX 360 serves institutions with everything they need throughout the entirety of their crypto journey.
  • "FalconX 360is extremely comprehensive, streamlining crypto management with unprecedented operational and capital efficiency," said Alessandro Balata, Portfolio Managerwith Fasanara Capital.
  • FalconX 360supports institutional investors in various stages of investing from first trade to more sophisticated portfolio management including staking, derivatives, and prime services.
  • FalconX Limited, FalconX Bravo, Inc., nor Solios, Inc. are registered with the Securities & Exchange Commission or the Financial Industry Regulatory Authority.

FalconX 360 Launches As The First and Only Comprehensive Platform for Institutional Crypto Investment Management

Retrieved on: 
星期四, 十月 13, 2022

SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- FalconX, a digital assets platform for institutional investors, today announced the launch of FalconX 360, the industry's first and only unified investment and risk management platform for crypto that provides institutional investors full-spectrum execution capabilities and end-to-end reporting across their entire digital asset portfolio.

Key Points: 
  • FalconX 360 serves institutions with everything they need throughout the entirety of their crypto journey.
  • "FalconX 360is extremely comprehensive, streamlining crypto management with unprecedented operational and capital efficiency," said Alessandro Balata, Portfolio Managerwith Fasanara Capital.
  • FalconX 360supports institutional investors in various stages of investing from first trade to more sophisticated portfolio management including staking, derivatives, and prime services.
  • FalconX Limited, FalconX Bravo, Inc., nor Solios, Inc. are registered with the Securities & Exchange Commission or the Financial Industry Regulatory Authority.

Immatics Announces $110 Million Underwritten Offering of Ordinary Shares

Retrieved on: 
星期一, 十月 10, 2022

The gross proceeds from the offering, before deducting the underwriting discount and offering expenses, are expected to be approximately $110 million.

Key Points: 
  • The gross proceeds from the offering, before deducting the underwriting discount and offering expenses, are expected to be approximately $110 million.
  • The offering is expected to close on October 12, 2022, subject to customary closing conditions.
  • Jefferies and SVB Securities are acting as joint book-running managers for the offering.
  • For example, statements concerning the closing of the public offering and gross proceeds therefrom are forward-looking statements.

BetterUp Appoints Psychologist Adam Grant as Chairman of Newly Launched Center for Purpose and Performance

Retrieved on: 
星期二, 十月 4, 2022

Today BetterUp , the human transformation company, announced that renowned psychologist Adam Grant, a bestselling author and current BetterUp Science Board member, is expanding his role with the company to serve as Chairman of BetterUps newly launched Center for Purpose and Performance.

Key Points: 
  • Today BetterUp , the human transformation company, announced that renowned psychologist Adam Grant, a bestselling author and current BetterUp Science Board member, is expanding his role with the company to serve as Chairman of BetterUps newly launched Center for Purpose and Performance.
  • The science reveals that performance and well-being cannot thrive without purpose, yet there is still a major disconnect around developing purpose within workplace cultures.
  • And, a strong sense of purpose at work is key to driving both these outcomes, said BetterUp CEO and Co-Founder Alexi Robichaux.
  • More information on this announcement and the BetterUp Center for Purpose and Performance can be found at Betterup.com/center-purpose-performance.

Revelation Partners Expands Team and Appoints New Partners Fred Lee and Liz Staley

Retrieved on: 
星期二, 十月 4, 2022

Revelation Partners provides liquidity and flexible capital solutions to investors, companies, limited partners and general partners across all healthcare sub-sectors, including medical devices, diagnostics, biotech, health-tech, and healthcare services.

Key Points: 
  • Revelation Partners provides liquidity and flexible capital solutions to investors, companies, limited partners and general partners across all healthcare sub-sectors, including medical devices, diagnostics, biotech, health-tech, and healthcare services.
  • Mr. Lee and Ms. Staley join Revelation's existing Partners, Mike Boggs, Scott Halsted and Dr. Doug Fisher.
  • Mr. Lee joined Revelation Partners in 2018 and has demonstrated a track record of identifying and leading new investments for Revelation Partners.
  • Prior to Revelation Partners, Fred worked as a Managing Director in the Life Sciences Group at Bridge Bank.

Cohen & Steers Announces Succession of Japan Country Head

Retrieved on: 
星期一, 十月 3, 2022

TOKYO and NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that effective today, Kazuya Yuasa has joined Cohen & Steers as a Senior Vice President.

Key Points: 
  • TOKYO and NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced that effective today, Kazuya Yuasa has joined Cohen & Steers as a Senior Vice President.
  • Effective January 1, 2023, Mr. Yuasa will succeed Ken Itai, who is retiring, as Head of Cohen Steers Japan Limited.
  • In addition to leading the operations of Cohen & Steers' Tokyo office, Mr. Yuasa will be responsible for enhancing the firm's existing client relationships and further expanding business in Japan, working closely with and reporting to Matthew Pace, Head of Global Relationship Management.
  • Kazuya will help Cohen & Steers continue the tradition of delivering exceptional client service achieved under Ken Itai's leadership.

Scribe Therapeutics to Participate in Upcoming Investor Conferences

Retrieved on: 
星期四, 九月 29, 2022

Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design platform for genetic medicine, today announced it will participate in two upcoming investor conferences:

Key Points: 
  • Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design platform for genetic medicine, today announced it will participate in two upcoming investor conferences:
    Scribe co-founder and CEO Benjamin Oakes will participate in a panel titled Gene Editing: Next-Generation Technologies Worth Watching, at 9:30 a.m.
  • ET on Oct. 3, 2022, at the Chardan Genetic Medicines Conference in New York, NY.
  • The companys management team will be available for one-on-one meetings with investors throughout the event, which is taking place Oct. 3-4, 2022.
  • Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease.